FINOX Biotech And Save The Children Switzerland Announce 0.12CHF (€0.10) Will Be Donated For Every Bemfola® Product Leaving The Swiss Factory.
7/3/2014 8:58:44 AM
Finox Biotech (Finox AG) and Save the Children Switzerland announced today a
wide ranging collaboration including the agreement that for every Bemfola®
product leaving the Swiss factory 0.12CHF (€0.10) will be donated to Save the
Children Switzerland for their charity projects across the world.
The donation is part of Finox Biotech’s wide ranging corporate social responsibility
program. Amongst other activities it is planned that executives and employees of
Finox Biotech will undertake field visits to Save the Children projects across the
Gavin Jelic-Masterton, Chief Executive of Finox Biotech commented, “it is very
exciting for us at Finox Biotech to be able to announce this important collaboration.
We are in the business of helping couples to become parents, and we know that
those couples will be thrilled to know that we as a company will be giving
something back to disadvantaged children across the world as a result of their
treatment. As a company we believe in the values that define Save the Children
Switzerland and their commitment to improving children’s lives through health,
famine relief, education, child protection, and emergency aid projects.”
Jérôme Strijbis, CEO of Save the Children Switzerland added “We at Save the
Children Switzerland are very grateful to be able to count on the support of Finox
Biotech in the future. For us the needs of children — whether it's clean water,
access to health care and education or relief after an emergency or natural disaster
— are the number one priority. Through Finox Biotech alignment with us, we will be
able to further transform children’s lives, changing the course of their futures and
making the world a better place for everybody.”
About Finox Biotech
Finox Biotech (FINOX AG) is a biopharmaceutical company with its corporate
headquarters in Burgdorf, Switzerland. Finox’ first product is BEMFOLA®, a
biosimilar r-FSH of GONAL-f®. Finox Biotech was founded in 2007 with a vision to
become a leading company in the field of fertility therapies, by combining high
quality Swiss medicines with innovative, award-winning delivery devices.
For further information please visit www.finoxbiotech.com or
contact us at: email@example.com / +41 (0)34 426 11 11, Finox Biotech
Technikumstrasse 2, 3401 Burgdorf, Switzerland
About Save the Children Switzerland
Save the Children is the world’s leading independent organisation for children.
Save the Children has been advocating for children’s rights in Switzerland since
2006 and works in over 120 countries.
We work in the fields of health and survival, school and education and protection
from exploitation and violence. We also support children and their families in
situations of emergencies. Save the Children has consultative status with the
United Nations Economic and Social Council (ECOSOC).
For further information please contact Sarah Frattaroli, Junior Project Manager
Communications, firstname.lastname@example.org, +41 44 267 74 85
Help employers find you! Check out all the jobs and post your resume.
comments powered by